Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03883217 · ClinicalTrials.gov registry record · NA
Optimizing Vibrational Therapy to Improve Gait and Balance in Parkinson's Disease
A NA study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT03883217 is a NA study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 12 participants.
The verdict
NCT03883217, a NA study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this research study is to test the safety, tolerability, and the effect of vibration (delivered by an experimental device called PDVibe2) on freezing of gait (FOG) in persons with Parkinson's disease (PD). The PDVibe2 was developed by Resonate Forward, LLC (RF). This PDVibe2 was designed to administer vibration therapy to the wearer to improve gait and balance in persons with PD while wearing the device.
Interventions
- DEVICE Vibration Session
- DEVICE No vibration session
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2021-06-29 |
| Est. Completion | 2022-01-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03883217
The ClinicalTrials.gov registry entry for NCT03883217 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vibration Session is the first listed.
NCT03883217 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03883217 about?
NCT03883217 is a clinical study titled "Optimizing Vibrational Therapy to Improve Gait and Balance in Parkinson's Disease". The purpose of this research study is to test the safety, tolerability, and the effect of vibration (delivered by an experimental device called PDVibe2) on freezing of gait (FOG) in persons with Parkinson's disease (PD). The PDVibe2 was developed by Resonate Forward, LLC (RF). This PDVibe2 was desig...
What is the current status of trial NCT03883217?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2021-06-29. Estimated completion is 2022-01-11.
What interventions are being tested in trial NCT03883217?
The interventions under investigation include: Vibration Session (DEVICE), No vibration session (DEVICE).
Who is sponsoring clinical trial NCT03883217?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.